开云app官网登录入口网页版-官方正版

#β阻滞剂#

21篇内容 | 1490人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=2183870, encodeId=a78821838e0c0, content=与接受安慰剂治疗的婴儿相比，早期接受<a href='/topic/show?id=197c484205b' target=_blank style='color:#2F92EE;'>#布洛芬#</a>治疗的婴儿<a href='/topic/show?id=ed183323e02' target=_blank style='color:#2F92EE;'>#动脉导管未闭#</a>，以及中度或重度<a href='/topic/show?id=33615e160c1' target=_blank style='color:#2F92EE;'>#支气管肺发育不良#</a>的风险并未显著出现降低。主要的理论依据是对抗<a href='/topic/show?id=53c66e0011b' target=_blank style='color:#2F92EE;'>#炎症#</a>，减少炎症，从而有望促进动脉导管未闭愈合，甚至在小规模临床研究中间接证实。但是经过严格的<a href='/topic/show?id=7591984530b' target=_blank style='color:#2F92EE;'>#随机对照试验#</a>则证伪了。可以这样说，抗炎也许有一定的作用，但是促进支气管与肺的发育更为重要，也许不是布洛芬，而是<a href='/topic/show?id=bf431925337' target=_blank style='color:#2F92EE;'>#β阻滞剂#</a>，如<a href='/topic/show?id=155a5100590' target=_blank style='color:#2F92EE;'>#心得安#</a>，是不是可能更有效？, objectTitle=NEJM：布洛芬早期治疗超早产儿动脉导管未闭效果如何？, objectType=article, longId=810854, objectId=69d5810854d8, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240125/1706151148590_5490734.jpg, objectUrl=/article/show_article.do?id=69d5810854d8, replyNumber=0, likeNumber=125, createdTime=2024-01-25, rootId=0, userName=侠胆医心, userId=f63e4754896, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=加利福尼亚, moduleDTOList=[ModuleDTO(moduleId=69d5810854d8, moduleTitle=NEJM：布洛芬早期治疗超早产儿动脉导管未闭效果如何？, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=69d5810854d8)], followStatus=false, userIsMember=false, type=1, lengthMark=1), GetTopicListResponse(id=1718239, encodeId=03731e1823931, content=<a href='/topic/show?id=bf431925337' target=_blank style='color:#2F92EE;'>#β阻滞剂#</a>, objectTitle=Can J Cardiol：加拿大声明称电风暴优选非选择性β阻滞剂, objectType=article, longId=199606, objectId=6ec41996063c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6ec41996063c, replyNumber=0, likeNumber=138, createdTime=2020-11-19, rootId=0, userName=zhzhxiang, userId=eaba32519184, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6ec41996063c, moduleTitle=Can J Cardiol：加拿大声明称电风暴优选非选择性β阻滞剂, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=6ec41996063c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1718238, encodeId=1a811e18238b4, content=<a href='/topic/show?id=bf431925337' target=_blank style='color:#2F92EE;'>#β阻滞剂#</a>, objectTitle=Am Heart J：出院时β阻滞剂处方不足70%！中国近三万非ST段抬高型急性冠脉综合征分析, objectType=article, longId=190793, objectId=9b03190e930f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9b03190e930f, replyNumber=0, likeNumber=65, createdTime=2021-02-26, rootId=0, userName=zhzhxiang, userId=eaba32519184, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9b03190e930f, moduleTitle=Am Heart J：出院时β阻滞剂处方不足70%！中国近三万非ST段抬高型急性冠脉综合征分析, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=9b03190e930f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1718237, encodeId=f08e1e18237b5, content=<a href='/topic/show?id=bf431925337' target=_blank style='color:#2F92EE;'>#β阻滞剂#</a>, objectTitle=澳大利亚研究称，亲人去世，β阻滞剂+阿司匹林可防“心碎”, objectType=article, longId=188003, objectId=0e4318800365, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0e4318800365, replyNumber=0, likeNumber=72, createdTime=2020-08-27, rootId=0, userName=zhzhxiang, userId=eaba32519184, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0e4318800365, moduleTitle=澳大利亚研究称，亲人去世，β阻滞剂+阿司匹林可防“心碎”, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=0e4318800365)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1718234, encodeId=5f751e182346f, content=<a href='/topic/show?id=bf431925337' target=_blank style='color:#2F92EE;'>#β阻滞剂#</a>, objectTitle=Lancet：代偿性肝硬化伴门脉高压症患者使用β阻滞剂可改善预后, objectType=article, longId=164757, objectId=7be1164e5777, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7be1164e5777, replyNumber=0, likeNumber=67, createdTime=2019-08-10, rootId=0, userName=zhzhxiang, userId=eaba32519184, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7be1164e5777, moduleTitle=Lancet：代偿性肝硬化伴门脉高压症患者使用β阻滞剂可改善预后, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=7be1164e5777)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1718235, encodeId=bc7e1e18235b9, content=<a href='/topic/show?id=bf431925337' target=_blank style='color:#2F92EE;'>#β阻滞剂#</a>, objectTitle=J Geriatr Cardiol:阜外医院周宪梁团队发现，β阻滞剂降白天血压有优势，利尿剂控制夜间血压好, objectType=article, longId=167270, objectId=9fef16e27098, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9fef16e27098, replyNumber=0, likeNumber=83, createdTime=2020-04-13, rootId=0, userName=zhzhxiang, userId=eaba32519184, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9fef16e27098, moduleTitle=J Geriatr Cardiol:阜外医院周宪梁团队发现，β阻滞剂降白天血压有优势，利尿剂控制夜间血压好, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=9fef16e27098)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1718236, encodeId=3c021e182364f, content=<a href='/topic/show?id=bf431925337' target=_blank style='color:#2F92EE;'>#β阻滞剂#</a>, objectTitle=冠心病应用β阻滞剂严重不规范！报告67家医院1.3万例冠心病患者数据, objectType=article, longId=181083, objectId=db6b181083ec, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=db6b181083ec, replyNumber=0, likeNumber=61, createdTime=2020-03-04, rootId=0, userName=zhzhxiang, userId=eaba32519184, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=db6b181083ec, moduleTitle=冠心病应用β阻滞剂严重不规范！报告67家医院1.3万例冠心病患者数据, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=db6b181083ec)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1718233, encodeId=c3b41e182339d, content=<a href='/topic/show?id=bf431925337' target=_blank style='color:#2F92EE;'>#β阻滞剂#</a>, objectTitle=PLos One：与心脏移植受者β阻滞剂和心率相关的尿蛋白质组学特征, objectType=article, longId=149589, objectId=2cc1149589c3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2cc1149589c3, replyNumber=0, likeNumber=100, createdTime=2018-11-07, rootId=0, userName=zhzhxiang, userId=eaba32519184, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2cc1149589c3, moduleTitle=PLos One：与心脏移植受者β阻滞剂和心率相关的尿蛋白质组学特征, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=2cc1149589c3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1718232, encodeId=82d51e18232a2, content=<a href='/topic/show?id=bf431925337' target=_blank style='color:#2F92EE;'>#β阻滞剂#</a>, objectTitle=ACC2018：得不偿失！围手术期大剂量β阻滞剂增加死亡风险, objectType=article, longId=132751, objectId=215d132e5113, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=215d132e5113, replyNumber=0, likeNumber=61, createdTime=2018-08-21, rootId=0, userName=zhzhxiang, userId=eaba32519184, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=215d132e5113, moduleTitle=ACC2018：得不偿失！围手术期大剂量β阻滞剂增加死亡风险, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=215d132e5113)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1718231, encodeId=6f4e1e18231cb, content=<a href='/topic/show?id=bf431925337' target=_blank style='color:#2F92EE;'>#β阻滞剂#</a>, objectTitle=Ann Oncol:β阻滞剂或可使三阴性乳腺癌患者的PFS增加2倍以上？, objectType=article, longId=108711, objectId=2c37108e1114, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2c37108e1114, replyNumber=0, likeNumber=72, createdTime=2017-12-23, rootId=0, userName=zhzhxiang, userId=eaba32519184, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2c37108e1114, moduleTitle=Ann Oncol:β阻滞剂或可使三阴性乳腺癌患者的PFS增加2倍以上？, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=2c37108e1114)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1718230, encodeId=25c61e1823048, content=<a href='/topic/show?id=bf431925337' target=_blank style='color:#2F92EE;'>#β阻滞剂#</a>, objectTitle=JAMA Intern Med：老年AMI患者使用β阻滞剂的利弊分析，全在这里！, objectType=article, longId=84560, objectId=74558456045, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=74558456045, replyNumber=0, likeNumber=71, createdTime=2017-03-30, rootId=0, userName=zhzhxiang, userId=eaba32519184, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=74558456045, moduleTitle=JAMA Intern Med：老年AMI患者使用β阻滞剂的利弊分析，全在这里！, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=74558456045)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1718229, encodeId=ffca1e1822917, content=<a href='/topic/show?id=bf431925337' target=_blank style='color:#2F92EE;'>#β阻滞剂#</a>, objectTitle=Pediatrics：妊娠后期暴露β阻滞剂增加婴儿低血糖和心动过缓风险, objectType=article, longId=76658, objectId=24a3e665804, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=24a3e665804, replyNumber=0, likeNumber=65, createdTime=2017-05-06, rootId=0, userName=zhzhxiang, userId=eaba32519184, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=24a3e665804, moduleTitle=Pediatrics：妊娠后期暴露β阻滞剂增加婴儿低血糖和心动过缓风险, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=24a3e665804)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1718228, encodeId=55ef1e182282f, content=<a href='/topic/show?id=bf431925337' target=_blank style='color:#2F92EE;'>#β阻滞剂#</a>, objectTitle=JASN：高透析率β阻滞剂或增透析者死亡风险, objectType=article, longId=42189, objectId=42da42189ac, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=42da42189ac, replyNumber=0, likeNumber=71, createdTime=2015-06-22, rootId=0, userName=zhzhxiang, userId=eaba32519184, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=42da42189ac, moduleTitle=JASN：高透析率β阻滞剂或增透析者死亡风险, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=42da42189ac)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1718227, encodeId=edad1e182271e, content=<a href='/topic/show?id=bf431925337' target=_blank style='color:#2F92EE;'>#β阻滞剂#</a>, objectTitle=β阻滞剂不能使无心梗病史的冠心病患者获益（CHARISMA试验）, objectType=article, longId=41256, objectId=60354125644, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=60354125644, replyNumber=0, likeNumber=64, createdTime=2014-11-12, rootId=0, userName=zhzhxiang, userId=eaba32519184, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=60354125644, moduleTitle=β阻滞剂不能使无心梗病史的冠心病患者获益（CHARISMA试验）, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=60354125644)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1718226, encodeId=47311e1822630, content=<a href='/topic/show?id=bf431925337' target=_blank style='color:#2F92EE;'>#β阻滞剂#</a>, objectTitle=ESC 2014：射血分数保留的AMI患者长期用β阻滞剂无益？（FAST-MI 2005）, objectType=article, longId=39843, objectId=6658398436e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6658398436e, replyNumber=0, likeNumber=84, createdTime=2015-02-01, rootId=0, userName=zhzhxiang, userId=eaba32519184, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6658398436e, moduleTitle=ESC 2014：射血分数保留的AMI患者长期用β阻滞剂无益？（FAST-MI 2005）, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=6658398436e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1718223, encodeId=72d61e182232d, content=<a href='/topic/show?id=bf431925337' target=_blank style='color:#2F92EE;'>#β阻滞剂#</a>, objectTitle=ACC 2014：早期静脉用β阻滞剂或可减少STEMI患者梗死面积, objectType=article, longId=32931, objectId=955232931f1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=955232931f1, replyNumber=0, likeNumber=84, createdTime=2014-09-22, rootId=0, userName=zhzhxiang, userId=eaba32519184, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=955232931f1, moduleTitle=ACC 2014：早期静脉用β阻滞剂或可减少STEMI患者梗死面积, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=955232931f1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1718225, encodeId=7f8e1e182257c, content=<a href='/topic/show?id=bf431925337' target=_blank style='color:#2F92EE;'>#β阻滞剂#</a>, objectTitle=JAMA Dermatol：高血压、长期用β阻滞剂或增银屑病风险, objectType=article, longId=37685, objectId=173d3e6857f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=173d3e6857f, replyNumber=0, likeNumber=92, createdTime=2015-03-07, rootId=0, userName=zhzhxiang, userId=eaba32519184, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=173d3e6857f, moduleTitle=JAMA Dermatol：高血压、长期用β阻滞剂或增银屑病风险, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=173d3e6857f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1718224, encodeId=c4c81e1822495, content=<a href='/topic/show?id=bf431925337' target=_blank style='color:#2F92EE;'>#β阻滞剂#</a>, objectTitle=JACC述评：β阻滞剂的不老神话, objectType=article, longId=36291, objectId=a4033629152, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a4033629152, replyNumber=0, likeNumber=119, createdTime=2015-05-11, rootId=0, userName=zhzhxiang, userId=eaba32519184, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a4033629152, moduleTitle=JACC述评：β阻滞剂的不老神话, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=a4033629152)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1718221, encodeId=d6671e1822194, content=<a href='/topic/show?id=bf431925337' target=_blank style='color:#2F92EE;'>#β阻滞剂#</a>, objectTitle=Heart：β阻滞剂和联用他汀改善急性心梗远期生存率更佳, objectType=article, longId=22368, objectId=c418223683b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c418223683b, replyNumber=0, likeNumber=57, createdTime=2014-04-14, rootId=0, userName=zhzhxiang, userId=eaba32519184, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c418223683b, moduleTitle=Heart：β阻滞剂和联用他汀改善急性心梗远期生存率更佳, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=c418223683b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1718222, encodeId=9f681e182222e, content=<a href='/topic/show?id=bf431925337' target=_blank style='color:#2F92EE;'>#β阻滞剂#</a>, objectTitle=JAMA：感染性休克患者应用β阻滞剂可达目标心率且不增加不良结局, objectType=article, longId=25519, objectId=8d4625519d1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8d4625519d1, replyNumber=0, likeNumber=104, createdTime=2014-04-03, rootId=0, userName=zhzhxiang, userId=eaba32519184, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8d4625519d1, moduleTitle=JAMA：感染性休克患者应用β阻滞剂可达目标心率且不增加不良结局, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=8d4625519d1)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 风湿免疫小助手

β阻滞剂

2020-05-29

侠胆医心 (审核中...)

前往app查看评论内容

全文收起与接受安慰剂治疗的婴儿相比，早期接受#布洛芬#治疗的婴儿#动脉导管未闭#，以及中度或重度#支气管肺发育不良#的风险并未显著出现降低。主要的理论依据是对抗#炎症#，减少炎症，从而有望促进动脉导管未闭愈合，甚至在小规模临床研究中间接证实。但是经过严格的#随机对照试验#则证伪了。可以这样说，抗炎也许有一定的作用，但是促进支气管与肺的发育更为重要，也许不是布洛芬，而是#β阻滞剂#，如#心得安#，是不是可能更有效？

NEJM：布洛芬早期治疗超早产儿动脉导管未闭效果如何？

2024-01-25发表于加利福尼亚

zhzhxiang (审核中...)

前往app查看评论内容

#β阻滞剂#

Can J Cardiol：加拿大声明称电风暴优选非选择性β阻滞剂

2020-11-19

zhzhxiang (审核中...)

前往app查看评论内容

#β阻滞剂#

Am Heart J：出院时β阻滞剂处方不足70%！中国近三万非ST段抬高型急性冠脉综合征分析

2021-02-26

zhzhxiang (审核中...)

前往app查看评论内容

#β阻滞剂#

澳大利亚研究称，亲人去世，β阻滞剂+阿司匹林可防“心碎”

2020-08-27

zhzhxiang (审核中...)

前往app查看评论内容

#β阻滞剂#

Lancet：代偿性肝硬化伴门脉高压症患者使用β阻滞剂可改善预后

2019-08-10

zhzhxiang (审核中...)

前往app查看评论内容

#β阻滞剂#

J Geriatr Cardiol:阜外医院周宪梁团队发现，β阻滞剂降白天血压有优势，利尿剂控制夜间血压好

2020-04-13

zhzhxiang (审核中...)

前往app查看评论内容

#β阻滞剂#

冠心病应用β阻滞剂严重不规范！报告67家医院1.3万例冠心病患者数据

2020-03-04

zhzhxiang (审核中...)

前往app查看评论内容

#β阻滞剂#

PLos One：与心脏移植受者β阻滞剂和心率相关的尿蛋白质组学特征

2018-11-07

zhzhxiang (审核中...)

前往app查看评论内容

#β阻滞剂#

ACC2018：得不偿失！围手术期大剂量β阻滞剂增加死亡风险

2018-08-21

zhzhxiang (审核中...)

前往app查看评论内容

#β阻滞剂#

Ann Oncol:β阻滞剂或可使三阴性乳腺癌患者的PFS增加2倍以上？

2017-12-23

zhzhxiang (审核中...)

前往app查看评论内容

#β阻滞剂#

JAMA Intern Med：老年AMI患者使用β阻滞剂的利弊分析，全在这里！

2017-03-30

zhzhxiang (审核中...)

前往app查看评论内容

#β阻滞剂#

Pediatrics：妊娠后期暴露β阻滞剂增加婴儿低血糖和心动过缓风险

2017-05-06

zhzhxiang (审核中...)

前往app查看评论内容

#β阻滞剂#

JASN：高透析率β阻滞剂或增透析者死亡风险

2015-06-22

zhzhxiang (审核中...)

前往app查看评论内容

#β阻滞剂#

β阻滞剂不能使无心梗病史的冠心病患者获益（CHARISMA试验）

2014-11-12

zhzhxiang (审核中...)

前往app查看评论内容

#β阻滞剂#

ESC 2014：射血分数保留的AMI患者长期用β阻滞剂无益？（FAST-MI 2005）

2015-02-01

zhzhxiang (审核中...)

前往app查看评论内容

#β阻滞剂#

ACC 2014：早期静脉用β阻滞剂或可减少STEMI患者梗死面积

2014-09-22

zhzhxiang (审核中...)

前往app查看评论内容

#β阻滞剂#

JAMA Dermatol：高血压、长期用β阻滞剂或增银屑病风险

2015-03-07

zhzhxiang (审核中...)

前往app查看评论内容

#β阻滞剂#

JACC述评：β阻滞剂的不老神话

2015-05-11

zhzhxiang (审核中...)

前往app查看评论内容

#β阻滞剂#

Heart：β阻滞剂和联用他汀改善急性心梗远期生存率更佳

2014-04-14

zhzhxiang (审核中...)

前往app查看评论内容

#β阻滞剂#

JAMA：感染性休克患者应用β阻滞剂可达目标心率且不增加不良结局

2014-04-03

科室
- - 订阅+
  - 更多科室
工具
服务